Diaxonhit and XDx Enter Into a Memorandum of Agreement for the Exclusive License to Market and Perform AlloMap[R] in Europe.
In: Pharma Business Week, 2013-06-17, S. 29
Zeitungsartikel
Zugriff:
Titel: |
Diaxonhit and XDx Enter Into a Memorandum of Agreement for the Exclusive License to Market and Perform AlloMap[R] in Europe.
|
---|---|
Zeitschrift: | Pharma Business Week, 2013-06-17, S. 29 |
Veröffentlichung: | 2013 |
Medientyp: | Zeitungsartikel |
ISSN: | 1543-6675 (print) |
Sonstiges: |
|